🔎 Trials Near Me

ホーム › 過体重 › ケンタッキー州 › Louisville

Louisville、KYにおける過体重の臨床試験

Louisvilleとその周辺地域(約30マイル以内)の拠点で、過体重に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

被験者募集中第3相
  • Louisville Metabolic and Atherosclerosis Research Center, Louisville
18歳〜99歳 · 全性別 · 2026/10/05更新 · NCT07684235

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第2相
  • L-MARC Research Center /ID# 282008, Louisville
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07752979

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

被験者募集中第3相
  • Monroe Biomedical Research, Louisville
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

被験者募集中第3相
  • Monroe Biomedical Research - Louisville, Louisville
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Gastroenterology Health Partners, Louisville
  • Gastroenterology Health Partners, New Albany · 4マイル先
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

被験者募集中第3相
  • Norton Children's Endocrinology, Louisville
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Gastroenterology Health Partners, Louisville
  • Gastroenterology Health Partners, New Albany · 4マイル先
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Monroe Biomedical Research - Louisville, Louisville
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Monroe Biomedical Research - Louisville, Louisville
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • Monroe Biomedical Research, Louisville
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

被験者募集中第3相
  • L-MARC Research Center, Louisville
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

被験者募集中第2相
  • Monroe Biomedical Research - Louisville, Louisville
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

被験者募集中第3相
  • Monroe Biomedical Research, LLC, Louisville
18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Louisville
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

被験者募集中第2相
  • Monroe Biomedical Research, Louisville
18歳〜60歳 · 全性別 · 2026/06/22更新 · NCT07570758

他の都市における過体重の試験

Louisvilleにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。